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ABSTRACT
The 16S ribosomal RNA methyltransferase enzymes
that modify nucleosides in the drug binding site
to provide self-resistance in aminoglycoside-
producing micro-organisms have been proposed
to comprise two distinct groups of S-adenosyl-L-
methionine (SAM)-dependent RNA enzymes,
namely the Kgm and Kam families. Here, the nucleo-
side methylation sites for three Kgm family methyl-
transferases, Sgm from Micromonospora zionensis,
GrmA from Micromonospora echinospora and Krm
from Frankia sp. Ccl3, were experimentally deter-
mined as G1405 by MALDI-ToF mass spectrometry.
These results significantly extend the list of securely
characterized G1405 modifying enzymes and exper-
imentally validate their grouping into a single
enzyme family. Heterologous expression of the
KamB methyltransferase from Streptoalloteichus
tenebrarius experimentally confirmed the require-
ment for an additional 60 amino acids on the
deduced KamB N-terminus to produce an active
methyltransferase acting at A1408, as previously
suggested by an in silico analysis. Finally, the mod-
ifications at G1405 and A1408, were shown to confer
partially overlapping but distinct resistance profiles
in Escherichia coli. Collectively, these data provide a
more secure and systematic basis for classification
of new aminoglycoside resistance methyltrans-
ferases from producers and pathogenic bacteria
on the basis of their sequences and resistance
profiles.
INTRODUCTION
The aminoglycoside antibiotic streptomycin was the ﬁrst
drug discovered through systematic screening of natural
products active against Mycobacterium tuberculosis in
1944 (1). In the following decades, many aminoglycosides
were isolated from soil bacteria, primarily the Gram-
positive actinomycetes of the genera Streptomyces
and Micromonospora (2,3). These antibiotics comprise a
structurally varied family of poly-cationic compounds
with a central aminocyclitol ring, most frequently
2-deoxystreptamine or streptamine, connected via glycosi-
dic bonds to amino sugars. The numerous hydroxyl and
primary amine groups of these substituents give aminogly-
cosides their overall positive charge and, based on their
position, deﬁne three distinct structural classes of drug.
The 4,6-disubstituted 2-deoxystreptamines (4,6-DOS)
include kanamycin and most clinically useful aminoglyco-
sides, such as gentamicin, tobramycin and amikacin.
The same core may alternatively be 4,5-disubstituted
(4,5-DOS) as in the aminoglycosides neomycin and paro-
momycin, while the ﬁnal group of compounds consists
of those that do not ﬁt into either of these groups,
such as apramycin, streptomycin, hygromycin B and
spectinomycin.
Various strategies have evolved in aminoglycoside anti-
biotic-producing micro-organisms to prevent self-intoxica-
tion, including mechanisms to decrease intracellular
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the drug itself, and multiple mechanisms can commonly
be found operating simultaneously in the cell (4).
Resistance by 16S rRNA methylation, accomplished by
S-adenosyl-L-methionine (SAM)-dependent rRNA resis-
tance methyltransferases (MTs), is a frequently occurring
mechanism alongside drug modiﬁcation in the aminogly-
coside-producing actinomycetes (5,6). Modiﬁcations at
two sites, G1405 and A1408, are thought to be incorpo-
rated by two diﬀerent methyltransferase protein families
(6–9). However, these sites of modiﬁcation have only
been experimentally determined as G1405 for KgmB
from Streptoalloteichus tenebrarius (10), formerly classiﬁed
as Streptomyces tenebrarius (11), and A1408 for KamA
(also known as IrmA) and KamC from Streptomyces
tenjimariensis and Saccharopolyspora hirsuta respectively
(5,9). Methylation sites have also been identiﬁed for
functionally equivalent methyltransferases from isolates
of bacterial pathogens, as G1405 for ArmA and RmtB,
and A1408 for NpmA (12–14). Typically, activity for
other MTs has been inferred indirectly by their inability
to further methylate ribosome subunits already protected
by one of these enzymes (15). Furthermore, although
it is clear that these base methylations can confer high-
level resistance to speciﬁc combinations of aminoglyco-
side antibiotics (5), despite their close proximity the
action spectra of each does not entirely overlap and few
systematic studies have been performed to date. The
emergence in the last decade of several plasmid-mediated
G1405 MTs among pathogenic Gram-negative rods from
both clinical and veterinary settings (16,17) and one
identiﬁcation of a novel A1408 resistance MT from patho-
gens (14), make thorough analysis of these resistance MT
enzymes, methylation targets and their conferred action
spectra essential.
Recently,thelimitedbiochemicaldataonactinomycetes’
G1405 MTs were enhanced by functional probing of Sgm,
the sisomicin-gentamicin aminoglycoside resistance MT
from Micromonospora zionensis. These studies demon-
strated the existence of two structural domains within
Sgm (18), and three functional classes of amino acids
responsible for SAM binding, target recognition and
methyl group transfer (19). Here, we describe experimental
identiﬁcation using mass spectrometry (MS) of the methyl-
ation site on 16S rRNA for Sgm and two further enzymes
from other actinomycetes genera, GrmA from Micromo-
nospora echinospora (formerly known as Micromonospora
purpurea), and the MT from Frankia sp. CcI3, for which we
will use the gene abbreviation krm (kanamycin resistance
MT) (Figure 1). Comparison of antibiotic resistance pat-
terns between Kgm and Kam family MTs unambiguously
identiﬁes functional diﬀerences correlating with modiﬁ-
cation at G1405 and A1408 in 16S rRNA.
MATERIALS AND METHODS
Phylogenetic analysis of different methyltransferase
families
Unique open reading frames (ORFs) of resistance MTs
were used to infer phylogenetic relationships within MT
groups proposed to modify G1405 and A1408. Amino
acid sequences were aligned using MUSCLE (20).
Maximum likelihood (ML) phylogenetic trees were calcu-
lated using PHYML (21,22), and the consensus tree was
calculated from 1000 ML trees by the bootstrap method of
Felsenstein (23).
Over expression and purification of resistance
methyltransferases
Construction of expression vectors for Sgm (24) and
KgmB (25) was described previously. DNA for other
enzymes were ligated into pQE-30 (Qiagen) following
either PCR ampliﬁcation of genomic DNA (grmA)o r
total gene synthesis (krm and kamB; GeneArt). All MTs
were expressed as 6 His-tagged proteins in Escherichia
coli BL21(DE3) and natively puriﬁed by Ni
2+ aﬃnity
chromatography (Ni
2+-NTA Agarose; Qiagen) as pre-
viously described for Sgm (19). The identity of each MT
protein was conﬁrmed by MS following in-gel trypsin
digestion of the excised SDS–PAGE bands (data not
shown).
Measurement of aminoglycoside MIC values in liquid
culture
Aminoglycoside minimal inhibitory concentrations (MIC)
were measured in triplicate in liquid culture for E. coli
strain BL21(DE3) harboring plasmid-encoded resistance
methyltransferase proteins as previously described (19).
Concentrations of gentamicin, kanamycin, neomycin, par-
omomycin, apramycin, hygromycin B and streptomycin
were varied in the range of 0 to 1000mg/ml. MIC values
are deﬁned as the minimal concentration of antibiotic
that prevents bacterial growth. Bacteria lacking a plasmid
or those transformed with an empty vector were used as
negative controls.
In vitro methylation of ribosomal subunits
Small ribosomal subunits were puriﬁed as previously
described (26). Methylation reaction mixtures contained
10mM HEPES-KOH pH 7.5, 10mM MgCl2,5 0 m M
NH4Cl, 5mM 2-mercaptoethanol, 1mM SAM, 100pmol
30S ribosomal subunits and 100ng of MT proteins.
Incubation was carried out at 378C for 60min. The reac-
tions were stopped by adding phenol–chloroform to
extract ribosomal proteins and MT enzyme, and 16S
rRNA was recovered by ethanol precipitation.
Matrix-assisted laser desorption/ionization time of flight
(MALDI-ToF) MS analysis of methylated 16S rRNA
16S rRNA was isolated from 30S particles previously
in vitro methylated (as described above), or from E. coli
BL21(DE3) cells expressing recombinant Sgm protein
(i.e. in vivo methylated). A deﬁned 16S rRNA sequence,
C1378-G1432, was isolated by hybridization to a
complementary deoxyoligonucleotide (27). 16S rRNA
(100pmol) was incubated with deoxyoligonucleotide
(1000pmol) at 958C for 5min in 200ml hybridization
buﬀer (250mM HEPES pH 7.5, 500mM KCl), followed
by slow cooling to 308C over 3h. Unhybridized regions
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nuclease (NEB) and 0.5mg RNase A (Sigma), for 60min
at 378C. The resulting DNA–RNA hybrid was recovered
by phenol–chloroform extraction and ethanol precipita-
tion. The target RNA sequence was excised from a 13%
polyacrylamide gel containing 7M urea, after visualiza-
tion with ethidium bromide, and puriﬁed using an
RNaid Spin Kit (MP Biochemicals). 3-hydroxypicolinic
acid (3-HPA; 0.5M, 1ml) was added to 2ml of the puriﬁed
55-mer RNA (30–40 pmol), and this digested with 40U
of RNase T1 for 16h at 378C. The resulting 30-cyclic phos-
phates were hydrolysed by adding 0.25 vol of 0.5M HCl
and incubating samples for 30min at room temperature.
Samples were air dried and redissolved in H2O. In some
cases, the RNA fragments were further puriﬁed using Zip
Tip
TM C18 according to the manufacturer’s instructions
(Millipore). Between 10 and 30pmol of the RNase T1
digest in 0.7mlH 2O was mixed with 0.7ml saturated
3-HPA in 50% acetonitrile/0.03M di-amonium citrate
and spotted on MALDI target plates. Mass spectra were
recorded in positive ion and either linear or reﬂectron
mode on a Kratos Shimadzu CFR MALDI-ToF MS as
previously described (28).
RESULTS
Phylogenetic relatedness of aminoglycoside resistance
16S rRNA methyltransferases
Aminoglycoside resistance MTs form a distinct group
within the SAM-dependent RNA methyltransferase
superfamily. Based on sequence similarity, all MTs pro-
posed to methylate G1405 on 16S rRNA are grouped in
the Pfam database as 16S rRNA MT with FmrO domain
(29). Within this group, MTs originating from both
G+C-rich and G+C-low bacteria (Gram-positive and
Gram-negative) are clustered together irrespective
of their phylogenetic relationships. To date, in addition
to nine distinct sequences from the actinomycetes, ﬁve
unique enzymes have been identiﬁed in Enterobacteriaceae,
Pseudomonas aeruginosa and Acinetobacter spp (30),
and together are classiﬁed as the Arm MTs (rmtA, rmtB,
rmtC, rmtD and armA). We analysed amino acid sequence
relatedness across this group of enzymes and identiﬁed
a general division between G1405 MTs from the actino-
mycetes producers and those found in pathogens
(Figure 1A). However, two enzymes from the actinomy-
cetes Micromonospora and Frankia genera, FmrO and
Krm, respectively, were found to cluster with MTs origi-
nating in pathogenic Gram-negative species. This obser-
vation supports the previous suggestion that pathogens
may have acquired their resistance MTs from unidentiﬁed
Gram-positive micro-organisms via horizontal gene trans-
fer (31,32).
In contrast, only a single example of a plasmid-
mediated A1408 MT resistance enzyme (NpmA) from
clinically isolated E. coli (14) has been identiﬁed in addi-
tion to the three distinct Kam MTs from the actinomy-
cetes (5,9) (Figure 1B), although it is highly likely
that further examples of this group will be identiﬁed
in the future. Since the evolutionary relationship of MT
enzymes from producers and pathogens in both groups is
not clear, we previously proposed classiﬁcation into four
distinct subfamilies based on their origin and target (31):
‘Kgm’ family (kanamycin–gentamicin MTs) in producers
and ‘Arm’ family (aminoglycoside resistance MTs) in
pathogens methylating G1405, and ‘Kam’ family (kana-
mycin–apramycin MTs) in producers and ‘Pam’ family
(pan-aminoglycoside resistance MTs) in pathogens methy-
lating A1408 residue. This classiﬁcation is supported by
our maximum likelihood analysis of sequence phylogenies
(Figure 1A and B). Two Kam MTs, CmnU and Kmr,
belong to the same clade as NpmA originating from the
pathogenic bacteria (Figure 1B), suggesting a possible
acquisition route for Pam MTs in pathogens. However,
for these two Kam MTs methylation sites are currently
unknown (33,34).
Identification of the Sgm target nucleoside
in 16S rRNA
Unmethylated and in vivo methylated 16S rRNA was
isolated from E. coli 30S ribosomal subunits and analysed
by MALDI-ToF MS to detect changes in methylation
patterns. MALDI-ToF MS can measure masses of small
RNAs with accuracy well below 150p.p.m., and thus the
presence or absence of a methyl group can be readily
identiﬁed by a mass diﬀerence of 14.02 Da. The preferred
RNA size for analysis is in the trinucleotide to dodeca-
nucleotide range. Therefore, molecules as large as 16S and
23S rRNAs require prior digestion with speciﬁc RNases to
yield fragments of suitable sizes (28). Fragmentation was
achieved by hybridization of a complementary deoxyoli-
gonucleotide to the 55nt sequence from C1378 to G1432
in 16S rRNA, digestion with nucleases and denaturing
PAGE isolation of the resulting 55-nt RNA. This was
followed by digestion of the puriﬁed RNA fragment
with RNase T1 to generate the ﬁnal short fragments for
analysis.
Comparison of RNase T1 fragment m/z signals from
unmethylated and in vivo Sgm methylated 16S rRNAs
reveals that the spectra are very similar, with only two
speciﬁc diﬀerences. Peaks at m/z 1307.22 and 3197.41,
that correspond to fragments 1402-C
2mCCG-1405 and
1406-U
mCACACCAUG-1415, respectively, are observed
in the unmethylated RNA spectrum but are completely
absent for the methylated sample (Figure 2A and B).
In contrast, the methylated RNA spectrum contains a
peak at m/z 4487.57 that is not observed in the unmethyl-
ated RNA (Figures 2 and 3). These observations are
entirely consistent with methylation of G1405 by Sgm.
The introduction of the methyl group on G1405 would
render this position resistant to RNase T1 cleavage (35),
resulting in a composite fragment for nts 1402–1415. This
sequence from 16S rRNA has three methyl groups origi-
nating from ‘house-keeping’ MTs that are located on
C1402 (dimethylated) and C1407 (36) (Figure 1C). These
methylations are also observed in the RNA from E. coli
not transformed with Sgm-encoding plasmid, and no
RNA unmethylated at these positions is observed (see
peak 30, 3 and 8 in Figure 2A). Thus, expression of Sgm
results in the sequence 1402-C
2mCCG
(m)UC
mACACCA
5422 Nucleic Acids Research, 2009, Vol. 37,No. 16UG-1415, where the additional methylation in parenthesis
is the conﬁrmed modiﬁcation by Sgm. The measured m/z
of 4501.73 for the largest ion correlates very well with the
theoretical m/z of 4501.80 for a tetramethylated sequence
(Figures 2A and 3C). Our data therefore conﬁrm both
these E. coli modiﬁcations and that Sgm methylates
G1405.
The major peak in the spectrum does not, however,
correspond to this most heavily modiﬁed fragment but
has an m/z of 4487.57, corresponding to a trimethylated
RNA (theoretical m/z 4487.78). This ion could result from
the loss of any one of the four methyl groups during the
MALDI process and is typical for measurements in the
reﬂectron ToF mode (36). Indeed, in addition to the minor
peak corresponding to four methylations at m/z 4501.73,
the major peak is accompanied by an additional minor
peak (Figure 3C) that corresponds to a dimethylated frag-
ment (m/z 4473.67), i.e. the loss of two methyl groups
(theoretical m/z 4473.76). To examine whether the triply
and doubly methylated RNAs might be formed during
the measurement from a 4-fold methylated precursor,
we examined the loss of methyl groups from the fully
methylated composite 1402-1415 RNA fragment (m/z
4501.73) in a post-source decay (PSD) experiment
(Figure 4). The ion gate was set to allow only ions from
m/z 4500–4560 (shaded region in the spectra of Figure 4)
into the ﬁeld-free drift region of the ToF tube with the
laser intensity increased to cause a higher degree of laser-
induced dissociation (LID). As expected, the parent ion
was measured at m/z 4501.46 and, in this mode of opera-
tion, all smaller ions must be fragments derived from this
ion. A strong fragment measured at m/z 4445.55, resulting
from the loss of all four methyl groups from the composite
1402–1415 RNA fragment was observed (Figure 4B). This
supports our hypothesis that the heterogeneity in the data
for the composite RNA fragment results from the loss of
methyl group(s) during the measurement and that the
fragment with the largest mass is methylated at four dif-
ferent sites, including by Sgm at G1405 (Figures 2B
and 3C). We do not observe any signals for the RNA
Figure 1. Phylogenetic relationship of 16S rRNA aminoglycoside resistance methyltransferase families. Consensus maximum likelihood phylogenetic
trees for proposed and conﬁrmed (denoted asterisk) (A) G1405 methyltransferases (Kgm and Arm families), and (B) A1408 methyltransferases
(Kam and Pam families). Bootstrap support is noted for each node, the bar represents amino acids substitutions per position. Methyltransferases
analysed in this study are shown in bold with all protein sequence accession numbers in the Pfam database (29) given in parenthesis after the strain
from which it was isolated. (C) Sequence and secondary structure of the 16S rRNA A-site surrounding the G1405 and A1408 target sites (shown in
outline font) for aminoglycoside antibiotic resistance methyltransferases.
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E. coli expressing Sgm and no signal for the composite
1402–1415 RNase T1 fragment in untransformed E. coli
(Figure 3). Taken together with the PSD data, we con-
clude therefore that the methylation of G1405 in E. coli
expressing Sgm is stoichiometric.
Analysis of in vitro methylation of 16S rRNA by other
members of the Kgm family and KamB
Our analysis of 16S rRNA fragments methylated in vivo
by Sgm conﬁrmed that this enzyme, like Kgm (5,7),
methylates G1405. To extend this analysis across the
Kgm family we selected two further G1405 MTs, includ-
ing the previously uncharacterized ‘Krm’ from Frankia sp.
CcI3. Although originating in a producer strain, this MT
aligns more closely with the group of G1405 MTs from
pathogenic bacteria in our sequence phylogeny analysis
(Figure 1A).
Puriﬁed small ribosomal subunits were incubated
in vitro with recombinant Sgm, GrmA and Krm MTs in
the presence of SAM, and isolated 16S rRNA fragments
were subjected to MALDI-ToF MS analysis as before.
Again, a composite fragment of nts 1402–1415 was
detected due to the inability of RNase T1 to cut at
m
7G1405 producing peaks at m/z  4487 and/or  4501
that correspond to tri- and tetramethylated fragments
respectively (Figure 5). We note that for Sgm the trimethy-
lated composite fragment is again predominant, while for
GrmA and Krm the tetramethylated RNA is observed.
Figure 2. MALDI-reﬂectron ToF MS analysis of Sgm in vivo methylated 16S rRNA. Spectra of fragments of 16S rRNA nucleotides 1378–1432
generated by digestion with RNase T1 for 30S subunits isolated from (A) E. coli transformed with empty pQE-30 vector (‘unmethylated’ 30S
subunits), and (B) E. coli expressing Sgm (in vivo methylated 30S ribosomal subunits). Theoretical and measured monoisotopic masses for expected
16S rRNA fragments are given in the tables. The average mass of the large composite fragment is shown (highlighted in italics).
5424 Nucleic Acids Research, 2009, Vol. 37,No. 16Since we would expect all samples to be similarly aﬀected
by loss of methyl groups in the instrument, this casts some
doubt on the idea that this mechanism leads to the tri-
methylated fragments for Sgm. An alternative explanation
that Sgm can somehow alter the methylation pattern
in this region other than at G1405, while GrmA and
Krm cannot, would require further investigation. Most
importantly, however, for each enzyme the composite
fragment can only be observed following methylation at
G1405 making the site resistant to RNase T1. Thus,
we present experimental conﬁrmation that each of these
MTs, together with KgmB, originating from diﬀerent
actinomycetes genera, constitute a family of 16S rRNA
G1405 MTs. Signals at m/z 1307 (fragment 1402–1405)
and m/z 3198 (fragment 1406–1415) corresponding to
the individual fragments without G1405 modiﬁcation
Figure 3. Details of spectral regions for fragments containing the G1405 target residue from control and Sgm in vivo methylated fragments. Spectra
of ‘unmethylated’ and in vivo Sgm methylated 16S rRNA in regions for (A) 1402–1405, (B) 1406–1415 and (C) the composite fragment 1402–1415
resistant to RNase T1 cleavage. Values indicated are monoisotopic, monoisotopic +1, and average masses in panels (A) to (C) respectively.
Nucleic Acids Research, 2009,Vol.37, No. 16 5425were also observed in all in vitro (Figure 5) but not in vivo
(Figures 2 and 4) methylated samples. This indicates that
30S subunits were only partially modiﬁed at the target
residue under the in vitro conditions used.
Finally, we examined one member of the Kam family,
KamB from S. tenebrarius, for which a modiﬁcation to
the originally suggested open reading frame was recently
proposed based upon in silico protein fold-recognition
analysis and modelling (37). The model indicated that
the Streptoalloteichus hindustanus KamB (CAI47641)
lacked a signiﬁcant part of the SAM-binding domain
and therefore could not be a functional methyltransferase
enzyme. Subsequent DNA sequence analysis of all kam
genes revealed a conserved region upstream of the start
codon originally suggested by Holmes et al. (9). Choosing
an alternative upstream translation initiation site within
the published gene sequence added 60 amino acids to the
deduced protein N-terminus and completed the expected
SAM-binding fold in the model (37). The KamB protein
expressed here contained this additional sequence at its
N-terminus. MALDI-ToF MS analysis of RNA frag-
ments from KamB methylated 16S rRNA identiﬁed an
additional fragment of m/z 3211.49 (Figure 6). This cor-
responds well with the predicted m/z 3211.47 for the
dimethylated RNA fragment that results from an
additional methylation of 1406-U
mCACACCAUG-1415
(theoretical m/z 3197.45) at A1408 by KamB. This site
of methylation is further supported by the complete
absence of any signal for the monomethylated form of
this prominent RNA fragment (compare Figures 3A, 3B
and 6B). Although the precise methylation site was not
determined here, a study on the closely related KamA
from S. tenjimariensis (Figure 1B) showed that methyla-
tion occurs at the N1 position of A1408 (5). Strikingly, in
contrast to the incomplete in vitro methylation by Kgm
family MTs, close to 100% eﬃciency was achieved under
the same conditions by KamB. We can only speculate on
the diﬀerences between the Kgm and Kam family MTs
tested that might cause this disparity though diﬀering
enzyme processivity or activity of puriﬁed enzymes are
the most obvious candidates since the 30S subunits used
in both experiments were from single preparation and
therefore of identical quality.
Resistance profiles conferred by the Kgm and
Kam family MTs
The minimum inhibitory concentrations (MICs) of ami-
noglycosides were measured using E. coli BL21(DE3)
transformants containing Kgm family and KamB MT-
encoding plasmids (Table 1). In liquid culture, all Kgm
family MTs conferred high-level resistance to 4,6-DOS
aminoglycosides tested (kanamycin and gentamicin),
with a MIC exceeding 1000mg/ml. A 3-fold increase in
resistance to hygromycin B was also observed (MIC
Figure 4. Post-source decay (PSD) analysis of composite RNA fragment 1402–1415 after Sgm in vivo methylation. (A) Three ions are observed for
the Sgm in vivo methylated composite 1402–1415 fragment, the largest of which is selected for PSD by setting the ion gate over the mass range
shaded grey. (B) PSD analysis of ion with m/z 4501.46. In both panels the theoretical average masses for the observed ions are shown with
Me denoting the number of attached methyl groups.
5426 Nucleic Acids Research, 2009, Vol. 37,No. 16Figure 5. Analysis of methylation target site for Kgm family MTs. Comparative analysis of RNA fragments after in vitro methylation of
30S ribosomal subunits by diﬀerent Kgm MTs. (A) Full MALDI-ToF MS spectra and (B) spectral details of potential RNA fragments
1402–1405, 1406–1415 and 1402–1415 (composite), for ‘unmethylated’ rRNA, Sgm in vivo methylated, and in vitro methylated with Sgm, GrmA
and Krm as noted on the spectra in panel (A). The measured average mass is indicated for each peak.
Nucleic Acids Research, 2009,Vol.37, No. 16 5427150mg/ml) (Table 1). However, susceptibilities to the
4,5-DOS aminoglycosides neomycin and paromomycin,
and also to apramycin and streptomycin were unaﬀected.
In contrast, E. coli BL21(DE3) containing KamB-
expressing plasmid had  40 times increased resistance
to neomycin in addition to high-level resistance to
kanamycin and apramycin (Table 1). Unlike the Kgm
family MTs, KamB MT did not confer resistance to gen-
tamicin. Growth on hygromycin B was comparable and
yielded a MIC value similar to that observed for Kgm
MTs (Table 1).
DISCUSSION
It is generally accepted that two 16S rRNA methylations,
m
7G1405 and m
1A1408, confer resistance to overlapping
sets of aminoglycoside antibiotics (4,31). However, very
little direct experimental evidence for the target site for
modiﬁcation previously existed for the majority of the
enzymes proposed to catalyse incorporation of these mod-
iﬁcations and systematic analyses of the resistance proﬁles
conferred are lacking. This is a particular concern since
resistance proﬁles often form a signiﬁcant part of the basis
for classiﬁcation of new 16S rRNA MT enzymes from
producer strains and pathogenic bacterial isolates
(34,38,39). Furthermore, confusion in the literature on
the origin and nature of certain aminoglycoside resistance
enzymes has compounded this problem. For example, it
was originally thought that the methylation site for GrmA
from M. echinospora (synonym M. purpurea) was success-
fully experimentally identiﬁed as G1405 (5), but this was
later shown to be KgmB from S. tenebrarius (7). Our study
has now experimentally demonstrated that three further
methyltransferases originating from diﬀerent actinomy-
cetes genera (Sgm, GrmA and Krm) methylate the 16S
rRNA residue G1405, as was shown for KgmB (5,7).
A potential resolution of a second historical point of
confusion with the Kam family of A1408 MTs was
recently suggested by Koscinski and colleagues (37) on
the basis of protein structure prediction and homology
searches. Initial studies on these enzymes used genomic
libraries from encoding strains to express the resistance
MTs from randomly cloned DNA fragments in
Streptomyces lividans and E. coli and observe resistance
phenotypes (9). However, the deposited ORF sequence
(NCBI accession number CAF33037) was shortened by
180nt encoding the Kam protein N-terminus that forms
the SAM-binding domain (37). Any attempt to express
KamB from the originally suggested start codon failed
and recombinant protein did not provide resistance to
any aminoglycoside antibiotics (Vasiljevic,B., unpublished
data). Therefore, although methylation of A1408 was
explicitly shown for kamA (imrA) from S. tenjimariensis
and kamC from S. hirsuta, their originally deduced protein
sequences of 156 amino acids are unlikely to confer resis-
tance due to the N-terminal truncation (37). Our analysis
of KamB from S. tenebrarius, thus experimentally con-
ﬁrms that these 60 additional N-terminal amino acids
are essential for a functional Kam family enzyme and
that it methylates at A1408 as predicted.
The Kgm and Kam enzymes share the Rossmann-like
fold that forms the SAM-binding and catalytic domain of
these MTs and, given the close proximity of their target
nucleosides, they must recognize a very similar molecular
surface of the 30S subunit. A key question is therefore
how the observed speciﬁcity of these enzymes is achieved.
Our data, together with recent structural probing of Sgm,
and in silico modelling studies of Kgm and Kam MTs
indicate that enzymes of each protein family adopt similar
Figure 6. KamB in vitro methylation of 30S ribosomal subunits. (A)
Full MALDI-ToF MS spectrum of RNA fragments after KamB
in vitro methylation. (B) Spectral region around fragment 1406–1415
(the same range as in Figure 3B) with the expected m/z of 3197.45
shifted to 3211.49 corresponding to methylation within this sequence.
Expected and measured monoisotopic masses are given in the table.
5428 Nucleic Acids Research, 2009, Vol. 37,No. 16topologies but diﬀer primarily in the order of the domains
(18,19,37). The co-enzyme/catalytic function is located in
the C-terminal domain of Kgm MTs but in the N-terminal
domain of Kam enzymes. The position of the additional
domain that is presumed to play the major role in target
recognition (18,19) is thus reversed in each family. We
would speculate that the domain order is the critical
factor contributing to the observed speciﬁcity of these
two enzymes families.
To eﬀectively provide resistance, modiﬁcation of G1405
and A1408 in the aminoglycoside binding pocket of the
30S A-site must perturb interaction between the drug and
its target residues in order to suﬃciently lower its aﬃnity
and thus eﬃcacy. Our results systematically establish
the link between the 16S rRNA modiﬁcation type and
aminoglycoside antibiotic resistance pattern conferred by
these modiﬁcations. Both groups of 2-DOS antibiotics
bind to 16S rRNA so that their Ring I substituents (see
chemical structures associated with Table 1) are placed in
close proximity to A1408. The methylated nucleotide
(m
1A1408) is positively charged at neutral pH, and can
therefore aﬀect drug binding not only by steric hindrance
but also by charge repulsion. This modiﬁcation confers
resistance to apramycin and the kanamycin group of
4,6-DOS aminoglycosides other than gentamicin. The
modiﬁcation does not, however, confer signiﬁcant resis-
tance to paromomycin (5) despite the observation of two
direct hydrogen bonds to A1408 in the crystal structure
Table 1. MIC values against three groups of aminoglycoside antibiotics for E.coli expressing Kgm and Kam family MTs
Aminoglycoside
antibiotic
Minimum inhibitory concentration (MIC) (mg/ml)
No vector pQE-30 pQE-Sgm pQE-GrmA pQE-Krm pQE-KgmB pQE-KamB
4,6-DOS
Kanamycin <5 <5 >1000 >1000 >1000 >1000 1000
Gentamicin <5 <5 >1000 >1000 >1000 >1000 10
4,5-DOS
Neomycin <5 <5 15 15 15 15 200
Paromomycin <5 <5 2 02 0 2 52 53 0
Others
Apramycin 15 15 30 20 20 15 1000
Streptomycin 10 10 15 15 15 15 15
Hygromycin B 50 50 150 150 150 150 150
Chemical structures of aminoglycosides tested: (A) 4,5-DOS: R1=H, R 2=NH 2/OH (neomycin/paromomycin), R3=OH, R4= ;
(B) 4,6-DOS: R1=H, R 2=NH 2,R 3=OH/H (Kanamycin A/Gentamicin C1A), R4=OH/H (K/G), R5=OH/NH2 (K/G), R6=H, R 7=H/CH3
(K/G), R8=H/OH (K/G), R9=OH/CH3 (K/G), R10=CH 2OH/H (K/G); (C) Hygromycin B; (D) Apramycin; (E) Streptomycin. In (C) and (D) the
aminocyclitol ring is shown green and in E the streptamine core is coloured blue.
Nucleic Acids Research, 2009,Vol.37, No. 16 5429of the antibiotic-30S complex (40). It is possible that
additional contacts made by other parts of these drugs
suﬃciently compensate for those lost near A1408.
Alternatively, secondary binding sites on the 70S ribosome
might account for the unaltered antibiotic susceptibility as
shown recently for paromomycin and gentamicin
which also bind to 23S rRNA helix 69 in the vicinity of
the P-site tRNA to inhibit ribosome recycling (41).
Paromomycin is also known to inhibit 30S subunit assem-
bly with approximately equal eﬃciency as it inhibits trans-
lation (42,43). Thus, simple protection of the primary
target site by methylation may not be suﬃcient to provide
resistance against these antibiotics.
In high-resolution structures of the 4,6-DOS aminogly-
cosides gentamicin C1a (44) and tobramycin (45) in com-
plex with A-site model RNAs, both antibiotics make
direct contacts to G1405 via their Ring III substituents.
Methylation of this nucleotide would thus directly inter-
fere with antibiotic binding, by inducing a steric clash
between the modiﬁed base and Ring III, in addition to
possible electrostatic repulsion by the positive charge on
modiﬁed nucleobase. In contrast, 4,5-DOS aminoglyco-
sides, such as paromomycin and neomycin, project their
substituent at position 5 at diﬀerent angle, directing it
away from G1405, so that methylation at this site does
not interfere with their binding. The m
7G1405 modiﬁca-
tion by Kgm MTs is thus only eﬀective against 4,6-DOS
aminoglycosides, but does confer high-level resistance
to both kanamycin and gentamicin antibiotic groups as
measured in our MIC analysis with several Kgm family
MTs (Table 1).
To date, aminoglycoside resistance spectra for Kgm
MTs were primarily analysed only in homologous host
strains, i.e. high G+C Gram-positive bacteria such as
S. lividans TK21 and Micromonospora melanosporea
(10,46). Our study therefore provides new functional
insight into the activity of these enzymes in the Gram-
negative heterologous host E. coli. We have shown that
all resistance MTs analysed, Sgm, GrmA, KgmB and
Krm, can confer high level resistance to 4,6-DOS antibio-
tics (Table 1) via modiﬁcation of G1405 of 16S rRNA in
E. coli. Each of these resistance MTs from three diﬀerent
actinomycetes genera is equally eﬀective in providing
high-level aminoglycoside resistance at a level comparable
to the original Gram-positive hosts. This observation
ﬁrmly establishes resistance MTs acquisition by Gram-
negative micro-organisms from surrounding Gram-
positive bacteria as a potential source of these enzymes
in pathogens.
Genes from Gram-positive organisms are known to
express in Gram-negative bacteria and recent data have
showed that although horizontal gene transfer is extensive
it is polarized in direction, from Gram-positive to Gram-
negative organisms (47). Therefore, it is possible for resis-
tance MT genes to transfer from antibiotic producing
Gram-positive bacteria to Gram-negative pathogens, sup-
porting the notion that Arm family MTs originated in
actinomycetes or related antibiotic-producing organisms
(48,49). This idea recently found an anchor point with
the realization of the tremendous potential of soil micro-
bial communities to overcome any antibiotic pressure and
even use antibiotics as sole carbon source to support
growth (50,51). This soil antibiotic resistome forms an
immense and diverse pool of resistance genes ready to
be mobilized into any micro-organism, including patho-
genic bacteria. This is undoubtedly a major factor in the
ability of pathogenic bacteria to rapidly develop resistance
to antibiotics and contribute to the increasing frequency of
multi-drug resistant isolates (52). As this global antibiotic
resistance problem has escalated, aminoglycosides have
assumed an increasing importance in clinical practice
due to their broad antimicrobial spectrum, rapid bacteri-
cidal action and ability to act synergistically with other
antibiotics, such as beta-lactams. A detailed understand-
ing of all resistance mechanisms for aminoglycosides will
therefore be an essential component of combating this
threat.
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